Building Novel DNA Constructs at ASM
News May 14, 2013
Integrated DNA Technologies (IDT) will host a user-orientated product theater presentation at the American Society of Microbiology (ASM) annual meeting (18-21 May, Denver, Colorado).
The presentation entitled ‘Rapid and Reliable Gene Construction with gBlocks™ Gene Fragments and Gibson Assembly™ Method’ will take place on 20 May, 11:00 am - 11:45 am in the Exhibit Hall, booth #1307.
Led by Dr Michel Cannieux, Director of Product Management at IDT, the presentation will offer first hand advice for bench scientists looking to build and modify novel DNA constructs with ease and speed.
Overcoming the costs and inefficiencies associated with traditional PCR techniques for the assembly of novel genes, IDT gBlocks Gene Fragments can be designed up to 500 base pairs and multiple fragments can be easily assembled for the generation of larger gene constructs.
The presentation will guide attendees through this process, offering practical advice for protocols and best practices, while providing insight into the wide range of biological applications and troubleshooting recommendations.
The workshop will give scientists a take-away understanding of how gBlocks can be used to proficiently build novel DNA sequences using the Gibson Assembly Method, in a more cost-effective, dependable manner.
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE